Hennion & Walsh Asset Management Inc. Has $2.20 Million Stock Position in Annexon, Inc. (NASDAQ:ANNX)

Hennion & Walsh Asset Management Inc. increased its stake in Annexon, Inc. (NASDAQ:ANNX) by 65.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 429,584 shares of the company’s stock after acquiring an additional 170,180 shares during the quarter. Hennion & Walsh Asset Management Inc. owned about 0.40% of Annexon worth $2,204,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Sandia Investment Management LP acquired a new position in Annexon in the second quarter valued at approximately $49,000. Victory Capital Management Inc. acquired a new position in Annexon in the second quarter valued at approximately $51,000. Quarry LP acquired a new position in Annexon in the third quarter valued at approximately $118,000. Intech Investment Management LLC acquired a new position in Annexon in the third quarter valued at approximately $154,000. Finally, SG Americas Securities LLC lifted its stake in Annexon by 117.8% in the third quarter. SG Americas Securities LLC now owns 32,763 shares of the company’s stock valued at $194,000 after buying an additional 17,723 shares during the period.

Wall Street Analysts Forecast Growth

ANNX has been the topic of several recent analyst reports. Cantor Fitzgerald reissued an “overweight” rating on shares of Annexon in a research note on Friday, November 15th. HC Wainwright reaffirmed a “buy” rating and set a $30.00 target price on shares of Annexon in a research report on Tuesday, December 17th. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $16.00 target price on shares of Annexon in a research report on Friday, November 15th. Six analysts have rated the stock with a buy rating, According to data from MarketBeat.com, Annexon currently has an average rating of “Buy” and a consensus target price of $15.80.

Annexon Stock Up 2.2 %

Shares of NASDAQ:ANNX opened at $4.20 on Friday. The stock’s 50 day moving average is $5.18 and its 200-day moving average is $5.92. Annexon, Inc. has a twelve month low of $3.86 and a twelve month high of $8.40. The firm has a market capitalization of $447.69 million, a price-to-earnings ratio of -4.00 and a beta of 1.11.

Annexon Profile

Annexon, Inc, a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases. Its lead candidate is ANX005, an investigational full-length monoclonal antibody, which is in Phase 3 clinical trial for the treatment of patients with guillain-barré syndrome; completed Phase II clinical trial for treating Huntington's disease; and in Phase II clinical trial for the treatment of amyotrophic lateral sclerosis.